General Information
Version
4
Revision date
2025-06-04
Product name
Remifentanil Hydrochloride Powder for Injection
Product Synonyms
Remifentanil Hydrochloride for Injection; Remifentanil HCl lyophilized powder for injection; Ultiva® for Injection; Remifentanil
1.2.1 Relevant identified uses
Pharmaceutical. Use only as directed The intent of this safety data sheet (SDS) is to provide safety information for occupational handling of this product. This information may not be relevant for medical use of this product. Patients/ consumers should ...
Emergency telephone
+1-813-248-0585, 1-800-255-39...
Icons in SDS
Company Information
company name
Viatris Inc
e-mail address of the competent person responsible for the Safety Data Sheet
SDScontact@viatris.com, druginfo@viatris.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H336
Hazard statements
Code
Statements
H336
May cause drowsiness or dizziness
Section 2
SECTION 2: Hazards identification
Pharmaceutical Agent – Handling of this product in its final form presents minimal occupational exposure risk Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions
2.1 Classification of the substance or mixture
Specific target organ toxicity (single exposure), Category 3 [ Narcotic effects ]
Signal word
Warning
Hazard statements
H336 - May cause drowsiness or dizziness
Prevention
Avoid breathing dust/fume/gas/mist/vapors/spray Use only outdoors or in a well-ventilated area
Response
Inhalation IF INHALED: Remove person to fresh air and keep comfortable for breathing Call a POISON CENTER or doctor if you feel unwell
Storage
Store in a well-ventilated place. Keep container tightly closed Store locked up
Precautionary statements
Disposal Dispose of contents/container to an approved waste disposal plant
Other hazards
No information available Unknown acute toxicity No information available
